A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: A pharmacokinetic and pharmacodynamic study

W. Kenneth Washburn, Lewis W. Teperman, Thomas G. Heffron, David D. Douglas, Steven Gay, Eliezer Katz, Goran B.G. Klintmalm

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: A pharmacokinetic and pharmacodynamic study'. Together they form a unique fingerprint.

Medicine & Life Sciences